| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6275994 | Neuroscience | 2011 | 12 Pages |
Abstract
â¶Electroconvulsive therapy improves motor symptoms in sporadic Parkinson's disease. â¶Electroconvulsive shock protects the nigrostriatal system against 6-OHDA toxicity. â¶Electroconvulsive shock stimulates the expression of GDNF in the substantia nigra. â¶GDNF is essential for electroconvulsive shock neuroprotective effect.
Keywords
6-OHDAGFAPN-methyl-d-aspartic acidGDNFSubstantia nigra pars reticulataMPTPNMDA1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineBDNFECsSNpcSNprelectroconvulsiveParkinson's diseasesubstantia nigrasubstantia nigra pars compactaDopamineelectroconvulsive shockTrophic factorGlial cell line-derived neurotrophic factorBrain-derived neurotrophic factoranterior–posteriorNeuroprotectionGlial fibrillary acidic protein
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
A. AnastasÃa, J. Wojnacki, G.A. de Erausquin, D.H. Mascó,